Abstract
Functional dyspepsia is a highly prevalent condition in the general population. Many allopathic and herbal therapies have been tried but with limited success. In this mini review, we will discuss the role, with scientific evidence, of peppermint oil (in combination with Caraway oil) in dyspeptic individuals.
Keywords: Functional Dyspepsia; Peppermint Oil; Caraway Oil; Helicobacter Pylori; Hypersensitivity
Introduction
Functional Gastro-Intestinal Disorders (FGIDs) have a huge impact on the general population in terms of high healthcare expenses and repeated physician consultations, both emergency and out-patient [1]. Among these, one of the most prevalent is Functional Dyspepsia (FD), carrying a global prevalence of 10% to 30% and thus vastly affecting the quality of life of the population as a whole [2]. According to the Rome IV criteria, dyspepsia has been defined as any combination of four symptoms: post-prandial fullness, early satiety, epigastric pain, and epigastric burning that are severe enough to interfere with the usual activities and occur at least 3 days per week over the last 3 months with an onset of at least 6 months in advance [3].
Pathophysiology of Functional Dyspepsia
The pathophysiology of FD is complex, key involving factors being visceral hypersensitivity, reduced gastric accommodation and emptying, active Helicobacter pylori (H. pylori) infection, abnormal small intestinal motility and psychological disorders [4]. Accordingly, the treatment armamentarium contains many pharmacological agents, ranging from histamine H2 receptor antagonists (H2 – blockers) and pro-kinetic drugs to antidepressants [4]. However, it has been our experience that despite being on treatment for longer periods of time, many patients continue to suffer from recurrent symptoms of FD. It has also been observed that many drugs used in this disorder lose their efficacy upon prolonged use. Hence the quest for a novel and effective therapeutic agent for this highly prevalent condition is still ongoing.
Role of Herbal Formulations in Functional Dyspepsia
Traditionally, there has been a lot of interest in phytomedical
drugs in the treatment of many FGIDs [5]. These natural herbal
remedies usually have a broader pharmacological coverage, are
thought have a safer side effect profile and are better tolerated than
synthetic formulations. One of such natural products is peppermint.
Peppermint (botanical name Mentha x Piperita), both as leaf and as
oil extract, has been in use since ancient times for treating disorders
of the digestive system [6]. Peppermint oil has been extensively
studied in various FGIDs notably irritable bowel syndrome (IBS)
and found to have positive results [7]. The proposed mechanism of
action seems to be calcium channel blockage in the gastrointestinal
(GI) tract, resulting in GI smooth muscle relaxation and visceral
pain reduction [8].
However, the therapeutic effects of peppermint oil in FD have
been mostly studied in combination with caraway oil (extracted
from the fruit of the plant Carum Carvi L), which is also wellknown
for its spasmolytic and anti-flatulent properties [9]. This blend of both the agents creates a synergistic effect required to
control the variety of symptoms associated with the disorder. The
combined formulation utilized in most studies consisted of an
enteric-coated capsule containing 90 mg peppermint oil and 50
mg caraway oil, administered for 28 days [10]. In one study, this
combination has been found to be efficacious and tolerable without
any side effects [11]. Similarly, a positive effect in controlling
troublesome symptoms of abdominal pain and discomfort (using
validated scales) and hence improving the overall quality of life in
such patients has been well demonstrated by several randomized,
double-blind, placebo-controlled trials [12,13]. Moreover, similar
efficacy was found when the drug combination was compared with
the pro-kinetic compound Cisapride, without having troublesome
side effects of pro-kinetic agents, for e.g. diarrhea [14].
It should, however, be kept in mind that peppermint oil is
not totally devoid of side effects. Consumed in high doses, it can
lead to kidney injury [15]. Because peppermint oil can decrease
the lower esophageal sphincter pressure and therefore make the
reflux symptoms worse, it is relatively contra-indicated in patients
with hiatal hernia and symptomatic gastro-esophageal reflux
disease (the effect intensifies even further with the combined
use of caraway oil) [16]. Similarly, being a choleretic, it can
exacerbate pain associated with cholelithiasis and cholecystitis
[16]. In addition, peppermint oil should also be used with caution
in pregnant ladies as it can initiate menstruation [16].
Conclusion
Peppermint oil in amalgamation with caraway oil seems to be a reasonable alternative for the sufferers of functional dyspepsia. However, studies are lacking regarding the long-term benefits of these agents, given the episodic nature of the condition. Additionally, therapeutic effect of peppermint oil in isolation in such patients is largely unknown and as such further studies are required in this regard.
References
- Tuppin P, Rivière S, Deutsch D, Gastaldi Menager C, Sabaté JM (2019) Burden of drug use for gastrointestinal symptoms and functional gastrointestinal disorders in France: a national study using reimbursement data for 57 million inhabitants. Ther Adv Gastroenterol 12.
- Kim SE, Kim N, Lee JY, Park KS, Shin JE, et al. (2018) Prevalence and Risk Factors of Functional Dyspepsia in Health Check-up Population: A Nationwide Multicenter Prospective Study. J Neurogastroenterol Motil 24(4): 603-613.
- Stanghellini V, Chan FK, Hasler WL, Malagelada JR, Suzuki H, et al. (2016) Gastroduodenal disorders. Gastroenterology 150(6): 1380-1392.
- Yamawaki H, Futagami S, Wakabayashi M, Sakasegawa N, Agawa S, et al. (2018) Management of functional dyspepsia: state of the art and emerging therapies. Ther Adv Chronic Dis 9(1): 23-32.
- Westphal J, Horning M, Leonhardt K (1996) Phytotherapy in functional upper abdominal complaints Results of a clinical study with a preparation of several plants. Phytomedicine 2(4): 285-291.
- Mills S, Bone K (2000) Principles and Practice of Phytotherapy. modern herbal medicine. WorldCat
- Alammar N, Wang L, Saberi B, Nanavati J, Holtmann G, et al. (2019) The impact of peppermint oil on the irritable bowel syndrome: a meta-analysis of the pooled clinical data. BMC Complement Altern Med 19(1): 21.
- Grigoleit HG, Grigoleit P (2005) Pharmacology and preclinical pharmacokinetics of peppermint oil. Phytomedicine 12(8): 612-616.
- Keshavarz A, Minaiyan M, Ghannadi A, Mahzouni P (2013) Effects of Carum carvi L. (Caraway) extract and essential oil on TNBS-induced colitis in rats. Res Pharm Sci 8(1): 1-8.
- May B, Kuntz HD, Kieser M, Kohler S (1996) Efficacy of a fixed peppermint oil/caraway oil combination in non-ulcer dyspepsia. Arzneimittelforschung 46(12): 1149-1153.
- May B, Kohler S, Schneider B (2000) Efficacy and tolerability of a fixed combination of peppermint oil and caraway oil in patients suffering from functional dyspepsia. Aliment Pharmacol Ther 14(12): 1671-1677.
- Rich G, Shah A, Koloski N, Funk P, Stracke B, et al. (2017) A randomized placebo-controlled trial on the effects of Menthacarin, a proprietary peppermint and caraway-oil-preparation, on symptoms and quality of life in patients with functional dyspepsia. Neurogastroenterol Motil 29(11).
- Holtmann G, Gschossmann J, Buenger L, Wieland V, Heydenreich CJ (2001) Effects of a fixed peppermint oil/caraway oil combination (PCC) on symptoms and quality of life in functional dyspepsia. Gastroenterology 120(5).
- Madisch A, Heydenreich CJ, Wieland V, Hufnagel R, Hotz J (1999) Treatment of functional dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to cisapride. A multicenter, reference-controlled double-blind equivalence study. Arzniemittelforschung 49(11): 925-932.
- Schulz V, Hänsel R, Tyler, Varro VE, Volker (2001) Rational Phytotherapy: Physician’s Guide to Herbal Medicine. Springer.
- Kligler B, Chaudhary S (2007) Peppermint oil. Am Fam Physician 75(7): 1027-1030.